InvestorsHub Logo

scottsmith

02/03/16 8:57 AM

#12691 RE: SJ2016 #12688

Yea initial pop then deflation. Different companies so we shall see, but I would expect TPIV to hold gains better than the other one.

BluMarlin1960

02/03/16 9:07 AM

#12693 RE: SJ2016 #12688

It doesn't need to do much, it is the sum of all parts that will propel the stock in the future.

With negotiations underway the DoD grant followed by Orphan Status and now Fast track it bodes very well from a bargaining position.

The FDA are one of the most time consuming/wasting entities when comes to granted trial approval so it is a big deal in that regard.

Also the last two approvals seem to show clearly that the FDA is on board with Tapimmune and it's direction and products.

It's like a puzzle we have another positive/relevant piece in place each individual piece, may not by itself be game changing but the sum of all parts is starting to show a clear and relevant story.

Very good news for the bargaining position they are involved in at the moment.

GLTA

BL:U

TomP1

02/03/16 9:13 AM

#12695 RE: SJ2016 #12688

Excellent news! Do not expect too much effect now the biotech love is over.

Another validation of our science.